Is Screening of Young Asymptomatic MEN1 Patients Necessary?

#1327

Introduction: Recent clinical practice guidelines recommend that routine screening of MEN1 mutation carriers should start at the age of 5 years to detect MEN1-associated tumors which is controversial in the scientific community.

Aim(s): Evaluation of the occurrence of clinically relevant MEN1 organ manifestations in children(<18 years).

Materials and methods: A prospective and retrospective collected data base of MEN1 patients who undergo an annual screening program was retrospectively analyzed for organ manifestations of MEN1 patients <18 years. The annual costs of a screening visit were calculated based on the German Diagnosis Related Groups.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Manoharan J, Lopez C, Albers M, Bollmann C, Slater E,

Keywords: Screening, MEN1,